Professional development Vacancies

Results of audits of applicants' pharmacovigilance systems for the period 2019-2021

12.04.2022 2842 views

As a result of the audits of applicants' pharmacovigilance systems for the period 2019-2021, the Center established the following:

  • 6 critical nonconformities;
  • 113 major nonconformities;
  • 11 minor nonconformities;

Figure 1. Summary data on identified non-conformities

Chart: summary data on non-compliances identified based on the results of pharmacovigilance system audits for 2019-2021

Critical non-conformities

Six critical non-conformities identified as a result of audits conducted during the reporting period were found in one applicant and related to the implementation of the relevant pharmacovigilance processes, namely regarding:

  • management of safety data, including the collection, evaluation, and submission to the State Expert Center of the MoH of information on adverse reactions/lack of efficacy of medicinal products, including signal detection and management;
  • updating information on medicinal products regarding safety and pharmacovigilance;
  • computerized systems and databases used by the applicant to receive, process, record, and provide safety information;
  • ensuring continuous monitoring of the benefit/risk balance of medicinal products;
  • pharmacovigilance quality system;
  • documentation of pharmacovigilance processes.

The applicant developed and agreed with the Center information on the timelines for corrective and preventive actions and, within the set deadline, submitted a report on the status of implementation of the corrective and preventive action plan, which indicated the elimination of the nonconformities identified during the audit through the implementation of corrective and preventive actions, taking into account the timelines for their completion.

Major non-conformities

As a result of audits conducted during the reporting period, one hundred thirteen major non-conformities were identified in eight applicants, relating to the performance of the relevant pharmacovigilance processes, namely regarding:

  • documentary confirmation of the delegation of pharmacovigilance in Ukraine (3,5%);
  • documentary confirmation of the authority, qualifications and procedure for substituting the UOVF/KOVF in Ukraine in case of absence, in order to ensure continuous pharmacovigilance activity (5,3%);
  • maintenance and updating of the applicant’s pharmacovigilance system master file (6,2%);
  • sources and management of safety data, including the collection, evaluation, and submission to the State Expert Center of the MoH of information on adverse reactions/lack of efficacy of medicinal products, including signal detection and management (6,2%);
  • ensuring interaction between the pharmacovigilance system and the quality control system for medicinal products (5,3%);
  • literature monitoring (7,1%);
  • computerized systems and databases used by the applicant to receive, process, record and provide safety information (4,4%);
  • planning, preparation, submission and evaluation of periodic safety update reports (6,2%);
  • establishment and maintenance of a risk management system (7,1%);
  • updating information on medicinal products regarding safety and pharmacovigilance (6,2%);
  • fulfillment of obligations and responses to requests from authorized bodies, providing correct, reliable information in full (5,3%);
  • communication on medicinal product safety issues between the applicant and the Center (6,2%);
  • informing patients and health care professionals on the safety of medicinal products (6,2%);
  • pharmacovigilance quality system (4,4%);
  • maintenance of pharmacovigilance documentation, including its storage and archiving (5,3%);
  • documentation of processes in pharmacovigilance (7,1%);
  • staff training for pharmacovigilance-related activities (6,2%).

To eliminate the identified nonconformities, seven applicants developed and agreed with the Center information on the timelines of corrective and preventive measures. The applicants submitted reports on the implementation of the corrective and preventive action plans agreed with the Center, which indicated that the identified nonconformities had been eliminated during the conducted nonconformity audits through the implementation of corrective and preventive measures, taking into account the deadlines for their completion.

For one applicant, the information on the timelines of corrective and preventive actions is at the processing stage.

Based on the results of the audit, for 4 applicants, in accordance with the measures proposed by the applicants to eliminate the nonconformities identified during the audit and agreed upon by the Center, there was a need to amend the registration dossier materials (amendments to the package insert, amendments to the pharmacovigilance system, submission of new versions of risk management plans, etc.).

Minor non-conformities

As a result of the audits conducted during the reporting period, eleven minor non-conformities were identified at six applicants relating to the implementation of the respective pharmacovigilance processes, namely concerning:

  • planning, preparation, submission and evaluation of periodic safety update reports;
  • maintenance and updating of the applicant’s Pharmacovigilance System Master File;
  • literature monitoring;
  • computerized systems and databases used by the applicant to receive, process, record, and provide safety information;
  • signal detection and management;
  • training of personnel to perform pharmacovigilance-related activities;
  • documentary confirmation of the authority of the KOVF in Ukraine;

The identified non-conformities were eliminated by the applicants in the course of routine work.